LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation (OTCBB: HEMA) today named Scott R. Burger, MD as the Chairperson of its Scientific Advisory Board. HemaCare has also engaged Dr. Burger, a world renowned cell therapy expert, in a comprehensive consulting services agreement. Dr. Burger will be a key agent in the aggressive expansion of HemaCare’s role in the rapidly developing fields of stem cells and cellular therapies, regenerative medicine, and immunotherapy.
